Skip to main content
. 2024 Nov 27;132(2):188–194. doi: 10.1038/s41416-024-02902-5

Table 2.

Overall response rates.

Evaluable patients Late Onset (n = 539) n(%) Early Onset (n = 614) n(%)
CR 51 (9.5) 46 (7.5)
PR 311 (57.7) 345 (56.2)
SD 142 (26.3) 147 (23.9)
PD 35 (6.5) 76 (12.4)
ORR 362 (67.2) 391 (63.7)
DCR 504 (93.5) 538 (87.6)